Tag: Research


Cannabis Sativa Economics and Sustainability

The following remarks were given by Elena Yaneva of SSDP Osterreich during the International Narcotic Control Board (INCB) civil society hearing on “the use of cannabis for medical and non-medical purposes”. The hearing took place on May 7th, 2018 in Vienna, Austria. I can’t hide the excitement triggered by the opportunity to discuss one of the topics I am most

Read more


SSDPers as Academics and Drug Policy Scholars

As SSDPers take on an impressive range of events, initiatives, and policy changes this semester, it is important to consider how these activities can be showcased in your academic and professional life. Many SSDPers will work to incorporate drug policy topics into coursework due to the interdisciplinary nature of reform work, which is such a fun way to blend your

Read more


Horizons: Perspectives on Psychedelics 2013 NYC Conference

        From October 11-13 a group of “scientists, artists, activists, seekers and scholars” will come together to learn about and discuss psychedelic drugs in the contexts of science, healing and spirituality. This event is an annual forum that brings people together to learn more about the uses and benefits of psychedelics. Among the distinguished speakers will be

Read more


Meet SSDP's Fall 2013 Intern Team!

Running a grassroots organization with more than 200 affiliated college chapters and an ample list of policy initiatives is no easy task. Joining the DC staff this fall semester are three interns working to promote SSDP’s mission and provide support. Dylan Bolduc, Michelle Higdon, and Tamara Omazic are each excited to be contributing to the cause. As the outreach intern,

Read more


On LSD's Medical Potential

This article originally published at the-libertarian.co.uk. As I mentioned in a recent article, the Multidisciplinary Association for Psychedelic Studies (MAPS) is funding MDMA PTSD research as its top priority. However, the organization also seeks to allow the medical use of certain other Schedule I drugs. These include the well-known psychedelic drug LSD, so called as an abbreviation for its German name, Lysergsäure-diathylamid

Read more